|
|
DSpace at RU >
Browsing by Author Sleijfer, S.
Showing results 1 to 5 of 5
| Full Text | Issue Date | Title | Author(s) | | 2011 | Immune responses to transgene and retroviral vector in patients treated with ex vivo-engineered T cells | Lamers, C.H.; Willemsen, R.; Elzakker, P. van; Steenbergen-Langeveld, S. van; Broertjes, M., et al |
| 2011 | The CYP2C19*2 genotype predicts tamoxifen treatment outcome in advanced breast cancer patients | Schaik, R.H. van; Kok, M. de; Sweep, F.C.; Vliet, M. van; Fessem, M. van, et al |
| 2008 | Angiogenesis inhibition in non-GIST soft tissue sarcomas. | Sleijfer, S.; Graaf, W.T.A. van der; Blay, J.Y. |
| 2008 | [Angiogenesis inhibitors for the systemic treatment of metastatic renal cell carcinoma: sunitinib, sorafenib, bevacizumab and temsirolimus] | Mulder, P.H.M. de; Haanen, J.B.; Sleijfer, S.; Kruit, W.H.; Gietema, J.A., et al |
| 2006 | Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience. | Lamers, C.H.; Sleijfer, S.; Vulto, A.G.; Kruit, W.; Kliffen, M., et al |
Showing results 1 to 5 of 5
|